Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis.
Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis.
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply.
Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in Children: Experience in a Tertiary Center, Upper Egypt.
Inflammatory demyelinating neuropathy heralding accelerated Chediak-Higashi syndrome.
Poster 487 Chronic Inflammatory Demyelinating Polyneuropathy or Something Else?: A Case Report.
Poster 353 Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) with CNS Involvement Initially Diagnosed as Guillain-Barre Syndrome (GBS): A Case Report.
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro.
Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis.
IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation.
Demographic-Based Content Analysis of Web-Based Health-Related Social Media.
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.
Inflammation severely alters thyroid hormone signaling in the central nervous system during experimental allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failure.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
MtDNA T4216C variation in multiple sclerosis: a systematic review and meta-analysis.
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
"A new imaging modality to non-invasively assess multiple sclerosis pathology".
TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury.
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
Pages
« first
‹ previous
…
807
808
809
810
811
812
813
814
815
…
next ›
last »